A Phase II Multicenter Study of the Efficacy and Safety Study of PNU-93914 [paclitaxel] (Liposome Encapsulated Paclitaxel) in Patients With Advanced Esophageal Cancer Previously Exposed to Chemotherapy
Phase of Trial: Phase II
Latest Information Update: 03 Feb 2010
At a glance
- Drugs Paclitaxel (Primary)
- Indications Oesophageal cancer
- Focus Therapeutic Use
- 03 Feb 2010 Last checked against ClinicalTrials.gov record.
- 17 Dec 2009 Actual end date (June 2001) added as reported by ClinicalTrials.gov.
- 17 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.